Detalhe da pesquisa
1.
Attitudes towards COVID-19 vaccination in adults with haematological malignancies.
Acta Haematol
; 2024 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38290477
2.
Long-term effectiveness of eculizumab: Data from the International PNH Registry.
Eur J Haematol
; 111(5): 796-804, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37712908
3.
Clinical characteristics of Australian treatment-naïve patients with classical Hodgkin lymphoma from the lymphoma and related diseases registry.
Eur J Haematol
; 110(4): 386-395, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36539351
4.
Paraprotein associated heparin resistance during cardiopulmonary bypass.
Perfusion
; 38(6): 1319-1321, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35700111
5.
Non-anaemic iron deficiency.
Aust Prescr
; 44(6): 193-196, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35002031
6.
Two monogenic disorders masquerading as one: severe congenital neutropenia with monocytosis and non-syndromic sensorineural hearing loss.
BMC Med Genet
; 21(1): 35, 2020 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32066420
7.
Phase II trials of zilucoplan in paroxysmal nocturnal hemoglobinuria.
Haematologica
; 109(3): 929-935, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37534517
8.
Recommendations for the use of pegylated interferon-α in the treatment of classical myeloproliferative neoplasms.
Intern Med J
; 49(8): 948-954, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30411442
9.
Humoral immune failure defined by immunoglobulin class and immunoglobulin G subclass deficiency is associated with shorter treatment-free and overall survival in Chronic Lymphocytic Leukaemia.
Br J Haematol
; 181(1): 97-101, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29468645
10.
Upfront lower dose lenalidomide is less toxic and does not compromise efficacy for vulnerable patients with relapsed refractory multiple myeloma: final analysis of the phase II RevLite study.
Br J Haematol
; 177(3): 441-448, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28197996
11.
TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets.
Blood
; 125(6): 915-23, 2015 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-25519749
12.
Clinicopathological differences exist between CALR- and JAK2-mutated myeloproliferative neoplasms despite a similar molecular landscape: data from targeted next-generation sequencing in the diagnostic laboratory.
Ann Hematol
; 96(5): 725-732, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28161773
13.
A case-based discussion of clinical problems in the management of patients treated with ruxolitinib for myelofibrosis.
Intern Med J
; 47(3): 262-268, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28260257
14.
Subacute combined degeneration of the spinal cord due to pernicious anaemia with an erroneously normal active B12 level.
Intern Med J
; 51(7): 1184-1185, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34278689
15.
Variable incidence of myeloproliferative neoplasms in Australia.
Intern Med J
; 51(11): 1979-1980, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34796634
16.
Cutaneous multiple myeloma.
Br J Haematol
; 190(2): 134, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32301114
17.
The oral iron chelator deferasirox inhibits NF-κB mediated gene expression without impacting on proximal activation: implications for myelodysplasia and aplastic anaemia.
Br J Haematol
; 168(4): 576-82, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25271366
18.
Correlation of blood counts with vascular complications in essential thrombocythemia: analysis of the prospective PT1 cohort.
Blood
; 120(7): 1409-11, 2012 Aug 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-22709688
19.
Changing incidence of myeloproliferative neoplasms in Australia, 2003-2014.
Am J Hematol
; 94(4): E107-E109, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30663086
20.
Hereditary haemorrhagic telangiectasia.
Med J Aust
; 210(1): 16-16.e1, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30636306